Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

July 7, 2023

Study Completion Date

August 28, 2023

Conditions
Cystic FibrosisChronic Pancreatitis
Interventions
DRUG

CREON

Capsule; Oral

Trial Locations (21)

26506

West Virginia University Hospitals /ID# 239593, Morgantown

32610

University of Florida - Archer /ID# 233411, Gainesville

32803

Central FL Pulmonary Orlando /ID# 245863, Orlando

33136

University of Miami, Miller School of Medicine /ID# 239415, Miami

44106

UH Cleveland Medical Center /ID# 246065, Cleveland

44195

Cleveland Clinic Main Campus /ID# 245864, Cleveland

65211

The Curators of the University of Missouri /ID# 233331, Columbia

74104

Options Health Research, LLC /ID# 239535, Tulsa

83687

Asr, Llc /Id# 239566, Nampa

93636

Valley Children's Hospital /ID# 231452, Madera

36608-1771

Velocity Clinical Research /ID# 231076, Mobile

33063-5737

Atlantic Medical Research /ID# 239568, Margate

34102-5449

GI Pros /ID# 239486, Naples

01655

UMass Chan Medical School /ID# 230476, Worcester

03756

Dartmouth-Hitchcock Medical Center /ID# 231633, Lebanon

12208-3504

Albany Medical College-Pulmonary /ID# 250041, Albany

10016-2708

NYU Langone Health /ID# 233417, New York

27157-0001

Wake Forest Baptist Health /ID# 229537, Winston-Salem

45267-0585

University of Cincinnati /ID# 229511, Cincinnati

77030-4202

Baylor College of Medicine Medical Center /ID# 233441, Houston

78229-3901

Univ Texas HSC San Antonio /ID# 239060, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY